Agachan, F., Chen, T., Pfeifer, J., Reissman, P., and Wexner, S.D. (1996). A constipation scoring system to simplify evaluation and management of constipated patients. Diseases Colon Rectum 39, 681–685.

Andrews, P., Borody, T.J., Shortis, N.P., and Thompson, S. (1995). Bacteriotherapy for chronic constipation—long term follow-up. Gastroen-terology 108, A563.

Aroniadis, O.C., and Brandt, L.J. (2013). Fecal microbiota transplantation. Curr Opin Gastroenterol 29, 79–84.

Barichella, M., Pacchetti, C., Bolliri, C., Cassani, E., Iorio, L., Pusani, C., Pinelli, G., Privitera, G., Cesari, I., Faierman, S.A., Caccialanza, R., Pezzoli, G., Cereda, E. (2016). Probiotics and prebiotic fiber for constipation associated with Parkinson disease. Neurology 87, 1274–1280.

Battaglia, E., Serra, A.M., Buonafede, G., Dughera, L., Chistolini, F., Morelli, A., Emanuelli, G., and Bassotti, G. (2004). Long-term study on the effects of visual biofeedback and muscle training as a therapeutic modality in pelvic floor dyssynergia and slow-transit constipation. Diseases Colon Rectum 47, 90–95.

Bharucha, A.E., Pemberton, J.H., and Locke Iii, G.R. (2013). American gastroenterological association technical review on constipation. Gastroenterology 144, 218–238.

Bustos Fernández, L.M., Prizont, R., and Soifer, L.O. (2013). A controlled pilot study on the efficacy of a low dose antibiotic for the treatment of chronic constipation in patients receiving a high fiber diet. Acta Gastroenterol Latinoamer 43, 275.

Camilleri, M., Kerstens, R., Rykx, A., and Vandeplassche, L. (2008). A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 358, 2344–2354.

Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., Segal, J., Aloi, M., Masucci, L., Molinaro, A., Scaldaferri, F., Gasbarrini, G., Lopez-Sanroman, A., Link, A., de Groot, P., de Vos, W.M., Högenauer, C., Malfertheiner, P., Mattila, E., Milosavljević, T., Nieuwdorp, M., Sanguinetti, M., Simren, M., Gasbarrini, A., Gasbarrini, A. (2017). European consensus conference on faecal microbiota transplantation in clinical practice. Gut 66, 569–580.

Celik, A.F., Tomlin, J., and Read, N.W. (1995). The effect of oral vancomycin on chronic idiopathic constipation. Aliment Pharmacol Ther 9, 63.

Chassagne, P., Ducrotte, P., Garnier, P., and Mathiex-Fortunet, H. (2017). Tolerance and long-term efficacy of polyethylene glycol 4000 (Forlax ®) compared to lactulose in elderly patients with chronic constipation. J Nutr Health Aging 21, 1–11.

Chaussade, S., Roche, H., Khyari, A., Couturier, D., and Guerre, J. (1986). Measurement of colonic transit time: description and validation of a new method (in French). Gastroenterol Clin Biol 10, 385–389.

Chiotakakou-Faliakou, E., Kamm, M.A., Roy, A.J., Storrie, J.B., and Turner, I.C. (1998). Biofeedback provides long term benefit for patients with intractable, slow and normal transit constipation. Gut 42, 517–521.

Chumpitazi, B.P., Self, M.M., Czyzewski, D.I., Cejka, S., Swank, P.R., and Shulman, R.J. (2016). Bristol Stool Form Scale reliability and agreement decreases when determining Rome III stool form designations. Neurogastroenterol Motil 28, 443–448.

Corazziari, E., Badiali, D., Bazzocchi, G., Bassotti, G., Roselli, P., Mastropaolo, G., Lucà, M.G., Galeazzi, R., and Peruzzi, E. (2000). Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut 46, 522–526.

Dalziel, J.E., Anderson, R.C., Peters, J.S., Lynch, A.T., Spencer, N.J., Dekker, J., and Roy, N.C. (2017). Promotility action of the probiotic Bifidobacterium lactis HN019 extract compared with prucalopride in isolated rat large intestine. Front Neurosci in press doi: 10.3389/fnins. 2017.00020.

de Meij, T.G.J., de Groot, E.F.J., Eck, A., Budding, A.E., Kneepkens, C.M. F., Benninga, M.A., van Bodegraven, A.A., and Savelkoul, P.H.M. (2016). Characterization of microbiota in children with chronic functional constipation. PLoS ONE 11, e0164731.

Dimidi, E., Christodoulides, S., Fragkos, K.C., Scott, S.M., and Whelan, K. (2014). The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 100, 1075–1084.

Ding, C., Ge, X., Zhang, X., Tian, H., Wang, H., Gu, L., Gong, J., Zhu, W., and Li, N. (2016). Efficacy of synbiotics in patients with slow transit constipation: a prospective randomized trial. Nutrients 8, 605.

Dipalma, J.A., Cleveland, M.V., McGowan, J., and Herrera, J.L. (2007). A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol 102, 1436–1441.

Drossman, D.A., Corazziari, E., Delvaux, M., Talley, N.J., Spiller, R., and Thompson, W.G. (2010). Rome III diagnostic criteria for functional gastrointestinal disorders. Revista De Gastroenterol De Mexico 75, 511–516.

Drossman, D.A., and Hasler, W.L. (2016). Rome IV—functional GI disorders: disorders of gut-brain interaction. Gastroenterology 150, 1257–1261.

Fischer, M., Sipe, B., Cheng, Y.W., Phelps, E., Rogers, N., Sagi, S., Bohm, M., Xu, H., and Kassam, Z. (2017). Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: a promising treatment approach. Gut Microbes 8, 289–302.

Fischer, M., Sipe, B.W., Rogers, N.A., Cook, G.K., Robb, B.W., Vuppalanchi, R., and Rex, D.K. (2015). Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Aliment Pharmacol Ther 42, 470–476.

Ford, A.C., Moayyedi, P., Lacy, B.E., Lembo, A.J., Saito, Y.A., Schiller, L. R., Soffer, E.E., Spiegel, B.M.R., Quigley, E.M.M., Quigley, E.M.M. (2014a). American college of gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 109, S2–S26.

Ford, A.C., Quigley, E.M.M., Lacy, B.E., Lembo, A.J., Saito, Y.A., Schiller, L.R., Soffer, E.E., Spiegel, B.M.R., and Moayyedi, P. (2014b). Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 109, 1547–1561.

Ge, X., Ding, C., Gong, J., Tian, H., Wei, Y., Chen, Q., Gu, L., and Li, N. (2016a). Short-term efficacy on fecal microbiota transplantation combined with soluble dietary fiber and probiotics in the treatment of slow transit constipation (in Chinese). Chin J Gastrointest Surgery 19, 1355–1359.

Ge, X., Ding, C., Zhao, W., Xu, L., Tian, H., Gong, J., Zhu, M., Li, J., and Li, N. (2017). Antibiotics-induced depletion of mice microbiota induces changes in host serotonin biosynthesis and intestinal motility. J Transl Med 15, 13.

Ge, X., Tian, H., Ding, C., Gu, L., Wei, Y., Gong, J., Zhu, W., Li, N., and Li, J. (2016b). Fecal microbiota transplantation in combination with soluble dietary fiber for treatment of slow transit constipation: a pilot study. Arch Med Res 47, 236–242.

Graf, D., Cagno, R.D., Fåk, F., Flint, H.J., Nyman, M., Saarela, M., and Watzl, B. (2015). Contribution of diet to the composition of the human gut microbiota. Biochem J 26, 477–480.

Ianiro, G., Valerio, L., Masucci, L., Pecere, S., Bibbò, S., Quaranta, G., Posteraro, B., Currò, D., Sanguinetti, M., Gasbarrini, A., Cammarota, G. (2017). Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study. Clin Microbiol Infect 23, 337.e1–337.e3.

Iwai, H., Ishihara, Y., Yamanaka, J., and Ito, T. (1973). Effects of bacterial flora on cecal size and transit rate of intestinal contents in mice. Jap J Exp Med 43, 297–305.

Kamm, M.A., Dudding, T.C., Melenhorst, J., Jarrett, M., Wang, Z., Buntzen, S., Johansson, C., Laurberg, S., Rosen, H., Vaizey, C.J., Matzel, K., Baeten, C. (2010). Sacral nerve stimulation for intractable constipation. Gut 59, 333–340.

Khalif, I.L., Quigley, E.M., Konovitch, E.A., and Maximova, I.D. (2005). Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 37, 838–849.

Mearin, F., Lacy, B.E., Chang, L., Chey, W.D., Lembo, A.J., Simren, M., and Spiller, R. (2016). Bowel disorders. Gastroenterology 150, 1393–1407.e5.

Lembo, A.J., Kurtz, C.B., Macdougall, J.E., Lavins, B.J., Currie, M.G., Fitch, D.A., Jeglinski, B.I., and Johnston, J.M. (2010). Efficacy of linaclotide for patients with chronic constipation. Gastroenterology 138, 886–895.e1.

Li, F., Fu, T., Tong, W.D., Liu, B.H., Li, C.X., Gao, Y., Wu, J.S., Wang, X. F., and Zhang, A.P. (2016). Lubiprostone Is effective in the treatment of chronic idiopathic constipation and irritable bowel syndrome. Mayo Clin Proc 91, 456–468.

Li, N., Tian, H., Ma, C., Ding, C., Ge, X., Gu, L., Zhang, X., Yang, B., Hua, Y., Zhu, Y., and Zhou, Y. (2017). Efficacy analysis of fecal microbiota transplantation in the treatment of 406 cases with gastrointestinal disorders (in Chinese). Chin J Gastrointest Surgery 20, 40–46.

Liu, Z., Yan, S., Wu, J., He, L., Li, N., Dong, G., Fang, J., Fu, W., Fu, L., and Sun, J. (2016). Acupuncture for chronic severe functional constipation: a randomized trial. Ann Intern Med 165, 761.

Metcalf, A.M., Phillips, S.F., Zinsmeister, A.R., MacCarty, R.L., Beart, R. W., and Wolff, B.G. (1987). Simplified assessment of segmental colonic transit. Gastroenterology 92, 40–47.

Michael, C., Hubert, P., Yan, Y., Jan, T., René, K., Quigley, E.M.M., Ke, M. Y., Da, S.S., and Amy, L. (2016). Efficacy and safety of prucalopride in chronic constipation: an integrated analysis of six randomized, controlled clinical trials. Dig Dis Sci 148, 2357–2372.

Moayyedi, P., Surette, M.G., Kim, P.T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J.K., Kassam, Z., Reinisch, W., Lee, C.H. (2015). Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149, 102–109.e6.

Ojetti, V., Ianiro, G., Tortora, A., D’Angelo, G., Di, R.T., Bibbò, S., Migneco, A., and Gasbarrini, A. (2014). The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. J Gastrointest Liver Dis 23, 387–391.

Paramsothy, S., Kamm, M.A., Kaakoush, N.O., Walsh, A.J., van den Bogaerde, J., Samuel, D., Leong, R.W.L., Connor, S., Ng, W., Paramsothy, R., Xuan, W., Lin, E., Mitchell, H.M., Borody, T.J. (2017). Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389, 1218–1228.

Parthasarathy, G., Chen, J., Chen, X., Chia, N., O’Connor, H.M., Wolf, P. G., Gaskins, H.R., and Bharucha, A.E. (2016). Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology 150, 367–379.e1.

Patton, V., Stewart, P., Lubowski, D.Z., Cook, I.J., and Dinning, P.G. (2016). Sacral nerve stimulation fails to offer long-term benefit in patients with slow-transit constipation. Dis Colon Rectum 59, 878.

Pikarsky, A.J., Singh, J.J., Weiss, E.G., Nogueras, J.J., and Wexner, S.D. (2001). Long-term follow-up of patients undergoing colectomy for colonic inertia. Diseases Colon Rectum 44, 179–183.

Rao, S.S., Rattanakovit, K., and Patcharatrakul, T. (2016). Diagnosis and management of chronic constipation in adults. Nat Rev Gastroenterol Hepatol 13, 295–305.

Stern, T., and Davis, A.M. (2016). Evaluation and treatment of patients with constipation. JAMA 315, 192–193.

Suares, N.C., and Ford, A.C. (2011). Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 106, 1582–1591.

Tack, J., van Outryve, M., Beyens, G., Kerstens, R., and Vandeplassche, L. (2009). Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 58, 357–365.

Tian, H., Ding, C., Gong, J., Ge, X., McFarland, L.V., Gu, L., Wei, Y., Chen, Q., Zhu, W., Li, J., Li, N. (2016). Treatment of slow transit constipation with fecal microbiota transplantation. J Clin Gastroenterol 50, 865–870.

Tian, H., Ge, X., Nie, Y., Yang, L., Ding, C., McFarland, L.V., Zhang, X., Chen, Q., Gong, J., Li, N. (2017). Fecal microbiota transplantation in patients with slow-transit constipation: a randomized, clinical trial. PLoS ONE 12, e0171308.

Webster, C., and Dayton, M. (2001). Results after colectomy for colonic inertia: a sixteen-year experience. Am J Surgery 182, 639–644.

Wei, Y., Gong, J., Zhu, W., Tian, H., Ding, C., Gu, L., Li, N., and Li, J. (2016). Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora. BMC Microbiol 16, 255.

Woodward, S., Norton, C., and Chiarelli, P. (2014). Biofeedback for treatment of chronic idiopathic constipation in adults. Cochrane Database Syst Rev 89, CD008486.

Yiannakou, Y., Piessevaux, H., Bouchoucha, M., Schiefke, I., Filip, R., Gabalec, L., Dina, I., Stephenson, D., Kerstens, R., Etherson, K., Levine, A. (2015). A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety and tolerability of prucalopride in men with chronic constipation. Am J Gastroenterol 110, 741–748.